|

Modified FOLFIRINOX Clinical Trials

3 actively recruiting trials across 2 locations

Pipeline

Phase 1: 2Phase 2: 1

Top Sponsors

  • Onconic Therapeutics Inc.1
  • EXACT Therapeutics AS1
  • Amgen1

Indications

  • Cancer3
  • Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers1
  • Locally Advanced Pancreatic Adenocarcinoma1
  • Pancreatic Ductal Adenocarcinoma1

Other1 trial

Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
Phase 1

Scottsdale, Arizona1 trial

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

HonorHealth Research Institute

Phase 2

Bakersfield, California1 trial

A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

Comprehensive Blood and Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.